Our study shows that METTL3 expression is increased in mycosis fungoides compared with the inflammatory disease lichen planus, revealing that elevated METTL3 expression may act as an oncogenic driver in CTCL progression. This evidence concerns the gene METTL3 and mycosis fungoides.